Retinal imaging company Optos is to acquire the instrumentation division of US firm Opko, which develops, manufactures and sells optical coherence tomography (OCT) diagnostic devices and optical ultrasound screeners.
Optos will pay an initial cash consideration of $17.5m on completion and the seller's royalty payments. Optos explained that its aim was to be the leading provider of devices for diagnosing and treating diseases and conditions presenting in the retina.
'Optos' widefield retinal imaging technology, combined with the specific data that can be derived from OCT images, has the potential to offer ophthalmologists and optometrists the most powerful tools for disease diagnosis and strengthens Optos' offering into optometry.'
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here